<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; compliant</title>
	<atom:link href="http://www.tapanray.in/tag/compliant/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality</title>
		<link>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality</link>
		<comments>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 07:13:04 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[compliant]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[Exclusivity]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Myth]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[pharmacuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[secret]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Trade]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[versus]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=703</guid>
		<description><![CDATA[THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in &#8230; <a href="http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory Data Protection (RDP) and its need in India: The Myth versus Reality</title>
		<link>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2</link>
		<comments>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 01:00:24 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[compliant]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[Exclusivity]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Myth]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[pharmacuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[secret]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Trade]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[versus]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=706</guid>
		<description><![CDATA[THE MYTH: An attempt to delay the launch of Indian generics: Some in India feel that Regulatory Data Protection (RDP), is a deliberate attempt by the innovator companies to delay the launch of the generic equivalent of patented products in &#8230; <a href="http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/regulatory-data-protection-rdp-and-its-need-in-india-the-myth-versus-reality-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Revised Mashelkar Committee Report recommends inclusion of ‘incremental innovation’ under patentability criteria.</title>
		<link>http://www.tapanray.in/revised-mashelkar-committee-report-recommends-inclusion-of-incremental-innovation-under-patentability-criteria/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=revised-mashelkar-committee-report-recommends-inclusion-of-incremental-innovation-under-patentability-criteria</link>
		<comments>http://www.tapanray.in/revised-mashelkar-committee-report-recommends-inclusion-of-incremental-innovation-under-patentability-criteria/#comments</comments>
		<pubDate>Sun, 26 Apr 2009 09:00:33 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Committee]]></category>
		<category><![CDATA[compliant]]></category>
		<category><![CDATA[criteria]]></category>
		<category><![CDATA[inclusion]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Mashelkar]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[patentability]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[recommends]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[Revised]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[under]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=906</guid>
		<description><![CDATA[In 2006, the Government of India appointed a Technical Expert Group (TEG) chaired by the eminent scientist and the then Director General of the Council of Scientific and Industrial Research (CSIR) Dr. R.A. Mashelkar, with the following terms of reference:1. &#8230; <a href="http://www.tapanray.in/revised-mashelkar-committee-report-recommends-inclusion-of-incremental-innovation-under-patentability-criteria/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/revised-mashelkar-committee-report-recommends-inclusion-of-incremental-innovation-under-patentability-criteria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
